Smoking and Cannabis Use Reduction for Pregnancy

(PICTURe Trial)

PC
Overseen ByProject Coordinator
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: University of Pittsburgh
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Using both tobacco and cannabis during pregnancy is more common in minoritized groups and can make quitting smoking in pregnancy and remaining smoke free postpartum difficult. Investigators will test an intervention to address prenatal depressive symptoms to encourage people to quit tobacco and cannabis during pregnancy and stay quit postpartum.

Who Is on the Research Team?

ND

Natacha De Genna

Principal Investigator

University of Pittsburgh

Are You a Good Fit for This Trial?

Inclusion Criteria

English speaking
Confirmed pregnant
Under 26 weeks gestation
See 3 more

Exclusion Criteria

Current opioid use or active treatment for Opioid Use Disorder
I am under 18 years old.
I cannot give informed consent in English.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive an intervention to address prenatal depressive symptoms to encourage quitting tobacco and cannabis during pregnancy

From enrollment to 3 months postpartum
Multiple sessions including baseline, pre-delivery, and postpartum assessments

Follow-up

Participants are monitored for abstinence from tobacco and cannabis, and changes in depressive symptoms

3 months postpartum
1 and 3 months postpartum assessments

What Are the Treatments Tested in This Trial?

Interventions

  • Perinatal smoking cessation treatment

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Feasibility and Acceptability TrialExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pittsburgh

Lead Sponsor

Trials
1,820
Recruited
16,360,000+

National Institute on Drug Abuse (NIDA)

Collaborator

Trials
2,658
Recruited
3,409,000+